Contact this trialFirst, we need to learn more about you.
Janus Kinase (JAK) Inhibitor
Ritlecitinib for Alopecia Areata
Recruiting0 awardsPhase 2
Raleigh, North Carolina
This trial is testing a new drug to treat hair loss in adults aged 18-50 due to Alopecia Areata. The trial is evaluating the safety and tolerability of the drug.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.